Showing results (281-290 of 678) with videos related to
Sort By:
Pageof 68
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2009
Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantationTrudy N Small, Andrew D Zelenetz, Ariela Noy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2013
Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT CTN 0401 trialJulie M Vose, Shelly Carter, Linda J Burns, et al.American Journal of Hematology|May 21, 2025
PET/CT in the Staging and Treatment Response Assessment of Patients With Extranodal Marginal Zone LymphomaJuan Pablo Alderuccio, Russ A Kuker, Eduardo Edelman Saul, et al.Haematologica|July 9, 2016
Definition of bulky disease in early stage Hodgkin lymphoma in computed tomography era: prognostic significance of measurements in the coronal and transverse planesAnita Kumar, Irene A Burger, Zhigang Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2003
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysisLauren E Abrey, Craig H Moskowitz, Warren P Mason, et al.Blood|January 24, 2004
Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphomaTarun Kewalramani, Andrew D Zelenetz, Stephen D Nimer, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 1, 2016
Prospective Study of 3'-Deoxy-3'-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell LymphomaHeiko Schöder, Andrew D Zelenetz, Paul Hamlin, et al.Blood|September 30, 2018
Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapseCraig H Moskowitz, Jan Walewski, Auayporn Nademanee, et al.Leukemia & Lymphoma|November 30, 2017
Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experienceLisa Giulino-Roth, Tara O'Donohue, Zhengming Chen, et al.Blood Advances|March 31, 2021
Involved-site radiotherapy for Helicobacter pylori-independent gastric MALT lymphoma: 26 years of experience with 178 patientsJoachim Yahalom, Amy J Xu, Ariela Noy, et al.Pageof 68